|
|
||||||||
CUTTING EDGE |




* Neuroinflammation Research Center, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195;
Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, United Kingdom;
University of Southern California, Los Angeles, CA 90089;
Immunobiology Center, Mount Sinai School of Medicine, New York, NY 10029; and
¶ National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709
D6, a promiscuous nonsignaling chemokine binding molecule expressed on the lymphatic endothelium, internalizes and degrades CC chemokines, and D6/ mice demonstrated increased cutaneous inflammation following topical phorbol ester or CFA injection. We report that D6/ mice were unexpectedly resistant to the induction of experimental autoimmune encephalomyelitis due to impaired encephalitogenic responses. Following induction with myelin oligodendroglial glycoprotein (MOG) peptide 3555 in CFA, D6/ mice showed reduced spinal cord inflammation and demyelination with lower incidence and severity of experimental autoimmune encephalomyelitis attacks as compared with D6+/+ littermates. In adoptive transfer studies, MOG-primed D6+/ T cells equally mediated disease in D6+/+ or D6/ mice, whereas cells from D6/ mice transferred disease poorly to D6+/ recipients. Lymph node cells from MOG-primed D6/ mice showed weak proliferative responses and made reduced IFN-
but normal IL-5. CD11c+ dendritic cells accumulated abnormally in cutaneous immunization sites of D6/ mice. Surprisingly, D6, a "silent" chemokine receptor, supports immune response generation.
This article has been cited by other articles:
![]() |
G. Trujillo, E. C. O'Connor, S. L. Kunkel, and C. M. Hogaboam A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., May 1, 2008; 172(5): 1209 - 1221. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |